Management of Paronychia Worsening with Cephalexin
Rationale for Antibiotic Switch
- The Infectious Diseases Society of America recommends switching to sulfamethoxazole-trimethoprim, such as Bactrim, for skin and soft tissue infections, particularly when MRSA is suspected, as it provides broader coverage than cephalexin 1
- Secondary bacterial or mycological superinfections are present in up to 25% of paronychia cases, which may not respond to cephalexin 3, 4
Assessment Before Switching
- Obtain bacterial, viral, and fungal cultures to identify potential resistant organisms or non-bacterial causes of infection 4
- Evaluate the severity of paronychia based on parameters including redness, edema, discharge, and granulation tissue 3, 5
Treatment Algorithm
- Discontinue cephalexin immediately and start Bactrim (sulfamethoxazole-trimethoprim) as it covers both gram-positive and gram-negative organisms 1, 2
- Apply topical povidone iodine 2% twice daily to the affected area 4, 2
Monitoring and Follow-up
- Reassess after 2 weeks of the new treatment regimen 3, 4
- If no improvement is seen, consider referral to dermatology or hand surgery for further evaluation 2